RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification

Medulloblastoma (MB) is the most common malignant brain tumor in children and is associated with a poor outcome. cMYC amplification characterizes a subgroup of MB with very poor prognosis. However, there exist so far no targeted therapies for the subgroup of MB with cMYC amplification. Here we used...

Descripción completa

Detalles Bibliográficos
Autores principales: Ćwiek, Paulina, Leni, Zaira, Salm, Fabiana, Dimitrova, Valeriya, Styp-Rekowska, Beata, Chiriano, Gianpaolo, Carroll, Michael, Höland, Katrin, Djonov, Valentin, Scapozza, Leonardo, Guiry, Patrick, Arcaro, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381582/
https://www.ncbi.nlm.nih.gov/pubmed/25402633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381582/
https://www.ncbi.nlm.nih.gov/pubmed/25402633

Ejemplares similares